Wikipedia

Inte:Ligand

(Redirected from Inte:ligand)

Inte:Ligand was founded in Maria Enzersdorf, Lower Austria (Niederösterreich) in 2003.[1] They established the company headquarters on Mariahilferstrasse in Vienna, Austria that same year.

Inte:Ligand GmbH
Company typePrivate
IndustryLife sciences
Founded2003
Headquarters
Vienna
,
Austria
Area served
Worldwide
Key people
Thierry Langer (Founder) Gerhard Wolber (Founder) Hermann Stuppner (Founder) Sharon D. Bryant (CEO)
ProductsLigandScout Essential LigandScout Advanced LigandScout Expert KNIME iLib:Diverse PharmacophoreDB
ServicesContract Research, In-Silico Library Design,

Lead Optimization Support, Virtual Screening, Activity Profiling, 3D-Pharmacophore Development,

Scientific Software Development
Websitewww.inteligand.com

In 2007 Inte:Ligand was the recipient of the NÖ Innovation prize (Innovationpreis) for the development of the simulation software LigandScout.[2][3][4][5] As of 2017 there were more than 1500 literature, book chapters and review articles published related to InteLigand software technology in the areas of virtual screening,[6][7][8] 3D-pharmacophore modeling,[9][10][11][12] hit identification,[13][14][15][16][17][18] medicinal chemistry decision support,[19][20][21] activity profiling,[22] docking, fragment-based compound design,[23] protein-protein-interactions,[24] drug-repurposing[25] and molecular dynamics simulations.[26][27][28]

Other applications include the discovery of new Myeloperoxidase ligands,[29] HIV reverse transcriptase inhibitors,[30] applications in anti-viral bio-activity profiling,[31] the development of models to predict HIV Protease activity,[32] Cytochrome P450 activity prediction ,[33] and simulation models for the activity on Factor Xa.[34]

Science and Technology

edit
  • LigandScout Essential, is a scientific software program for de novo molecule design, to derive structure-based and ligand-based 3D pharmacophores, perform molecular 3D alignments, 3D pharmacophore modeling, virtual screening, create multi-conformational compound libraries for virtual screening, annotate compound libraries and perform filtering and sorting and advanced pharmacophore and molecule editing.
  • LigandScout Advanced, is a scientific software program that has all of the functionality of LigandScout Essential plus docking, Apo site pharmacophore modeling, pocket finding, analysis of molecular dynamics trajectories.
  • LigandScout Expert KNIME Extensions provide more than 45 Inte:Ligand scientific algorithms wrapped into KNIME extensions to be used for designing customized workflows related to computer aided drug design using the platform KNIME.

See also

edit

Other companies and institutions providing drug discovery software:

References

edit
  1. ^ "Inte:Ligand Software-Entwicklungs- und Consulting GmbH - Wien - Telefon - Kontakt - Information und Consulting - Firmen A-Z". firmen.wko.at (in Austrian German). Retrieved 2017-07-02.
  2. ^ Wolber, Gerhard; Dornhofer, Alois A.; Langer, Thierry (2006-12-01). "Efficient overlay of small organic molecules using 3D pharmacophores". Journal of Computer-Aided Molecular Design. 20 (12): 773–788. Bibcode:2006JCAMD..20..773W. doi:10.1007/s10822-006-9078-7. ISSN 0920-654X. PMID 17051340. S2CID 31986330.
  3. ^ "Land Niederösterreich und Wirtschaftskammer NÖ verleihen NÖ Innovationspreis 2007". OTS.at. Retrieved 2017-07-02.
  4. ^ "Waldviertelnews.at". www.waldviertelnews.at. Retrieved 2017-07-02.
  5. ^ Wolber, Gerhard; Langer, Thierry (2005-01-01). "LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters". Journal of Chemical Information and Modeling. 45 (1): 160–169. doi:10.1021/ci049885e. ISSN 1549-9596. PMID 15667141.
  6. ^ Karaboga, Arnaud S.; Planesas, Jesús M.; Petronin, Florent; Teixidó, Jordi; Souchet, Michel; Pérez-Nueno, Violeta I. (2013-05-24). "Highly SpecIfic and Sensitive Pharmacophore Model for Identifying CXCR4 Antagonists. Comparison with Docking and Shape-Matching Virtual Screening Performance". Journal of Chemical Information and Modeling. 53 (5): 1043–1056. doi:10.1021/ci400037y. ISSN 1549-9596. PMID 23577723.
  7. ^ Sanders, Marijn P. A.; Barbosa, Arménio J. M.; Zarzycka, Barbara; Nicolaes, Gerry A.F.; Klomp, Jan P.G.; de Vlieg, Jacob; Del Rio, Alberto (2012-06-25). "Comparative Analysis of Pharmacophore Screening Tools". Journal of Chemical Information and Modeling. 52 (6): 1607–1620. doi:10.1021/ci2005274. ISSN 1549-9596. PMID 22646988.
  8. ^ Kaserer, T.; Obermoser, V.; Weninger, A.; Gust, R.; Schuster, D. (2016-11-29). "Evaluation of selected 3D virtual screening tools for the prospective identification of peroxisome proliferator-activated receptor (PPAR) γ partial agonists". European Journal of Medicinal Chemistry. 124: 49–62. doi:10.1016/j.ejmech.2016.07.072. PMID 27560282.
  9. ^ Seidel, Thomas; Bryant, Sharon D.; Ibis, Gökhan; Poli, Giulio; Langer, Thierry (2017). Varnek, Alexandre (ed.). Tutorials in Chemoinformatics. John Wiley & Sons, Ltd. pp. 279–309. doi:10.1002/9781119161110.ch20. ISBN 9781119161110.
  10. ^ Lagarde, Nathalie; Delahaye, Solenne; Zagury, Jean-François; Montes, Matthieu (2016-09-06). "Discriminating agonist and antagonist ligands of the nuclear receptors using 3D-pharmacophores". Journal of Cheminformatics. 8 (1): 43. doi:10.1186/s13321-016-0154-2. ISSN 1758-2946. PMC 5011875. PMID 27602059.
  11. ^ Liu, Jiyuan; Tian, Zhen; Zhang, Yalin (2016-10-06). "Structure-based discovery of potentially active semiochemicals for Cydia pomonella (L.)". Scientific Reports. 6 (1): 34600. Bibcode:2016NatSR...634600L. doi:10.1038/srep34600. ISSN 2045-2322. PMC 5052595. PMID 27708370.
  12. ^ Wolber, Gerhard; Kosara, Robert (2006). Langer, Thierry; Hoffmann, Rémy D. (eds.). Pharmacophores and Pharmacophore Searches. Wiley-VCH Verlag GmbH & Co. KGaA. pp. 131–150. doi:10.1002/3527609164.ch6. ISBN 9783527609161.
  13. ^ Langer, Thierry; Hoffmann, Rémy; Bryant, Sharon; Lesur, Brigitte (2009). "Hit finding: towards 'smarter' approaches". Current Opinion in Pharmacology. 9 (5): 589–593. doi:10.1016/j.coph.2009.06.001. PMID 19576852.
  14. ^ Takimoto, Seisuke; Sugiura, Airi; Minami, Saki; Tasaka, Tomohiko; Nakagawa, Yoshiaki; Miyagawa, Hisashi (2016-04-01). "In silico exploration for agonists/antagonists of brassinolide". Bioorganic & Medicinal Chemistry Letters. 26 (7): 1709–1714. doi:10.1016/j.bmcl.2016.02.054. PMID 26935445.
  15. ^ Vuorinen, Anna; Engeli, Roger; Meyer, Arne; Bachmann, Fabio; Griesser, Ulrich J.; Schuster, Daniela; Odermatt, Alex (2014-07-24). "Ligand-Based Pharmacophore Modeling and Virtual Screening for the Discovery of Novel 17β-Hydroxysteroid Dehydrogenase 2 Inhibitors". Journal of Medicinal Chemistry. 57 (14): 5995–6007. doi:10.1021/jm5004914. ISSN 0022-2623. PMC 4111740. PMID 24960438.
  16. ^ Perdih, Andrej; Kovač, Andreja; Wolber, Gerhard; Blanot, Didier; Gobec, Stanislav; Solmajer, Tom (2009-05-15). "Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach". Bioorganic & Medicinal Chemistry Letters. 19 (10): 2668–2673. doi:10.1016/j.bmcl.2009.03.141. PMID 19369074.
  17. ^ Waltenberger, Birgit; Garscha, Ulrike; Temml, Veronika; Liers, Josephine; Werz, Oliver; Schuster, Daniela; Stuppner, Hermann (2016-04-25). "Discovery of Potent Soluble Epoxide Hydrolase (sEH) Inhibitors by Pharmacophore-Based Virtual Screening". Journal of Chemical Information and Modeling. 56 (4): 747–762. doi:10.1021/acs.jcim.5b00592. ISSN 1549-9596. PMID 26882208.
  18. ^ Voet, Arnout R. D.; Kumar, Ashutosh; Berenger, Francois; Zhang, Kam Y. J. (2014-04-01). "Combining in silico and in cerebro approaches for virtual screening and pose prediction in SAMPL4". Journal of Computer-Aided Molecular Design. 28 (4): 363–373. Bibcode:2014JCAMD..28..363V. doi:10.1007/s10822-013-9702-2. ISSN 0920-654X. PMID 24446075. S2CID 13467787.
  19. ^ DeBonis, Salvatore; Skoufias, Dimitrios A.; Indorato, Rose-Laure; Liger, François; Marquet, Bernard; Laggner, Christian; Joseph, Benoît; Kozielski, Frank (2008-03-01). "Structure–Activity Relationship of S-Trityl-l-Cysteine Analogues as Inhibitors of the Human Mitotic Kinesin Eg5". Journal of Medicinal Chemistry. 51 (5): 1115–1125. doi:10.1021/jm070606z. ISSN 0022-2623. PMID 18266314.
  20. ^ Polishchuk, Pavel G.; Samoylenko, Georgiy V.; Khristova, Tetiana M.; Krysko, Olga L.; Kabanova, Tatyana A.; Kabanov, Vladimir M.; Kornylov, Alexander Yu.; Klimchuk, Olga; Langer, Thierry (2015-10-08). "Design, Virtual Screening, and Synthesis of Antagonists of αIIbβ3 as Antiplatelet Agents". Journal of Medicinal Chemistry. 58 (19): 7681–7694. doi:10.1021/acs.jmedchem.5b00865. ISSN 0022-2623. PMID 26367138.
  21. ^ Barreca, Maria Letizia; De Luca, Laura; Iraci, Nunzio; Rao, Angela; Ferro, Stefania; Maga, Giovanni; Chimirri, Alba (2007-03-01). "Structure-Based Pharmacophore Identification of New Chemical Scaffolds as Non-Nucleoside Reverse Transcriptase Inhibitors". Journal of Chemical Information and Modeling. 47 (2): 557–562. doi:10.1021/ci600320q. ISSN 1549-9596. PMID 17274611.
  22. ^ Langer, Thierry; Bryant, Sharon D (2013-10-01). "Computational methods for drug target profiling and polypharmacology". In Silico Drug Discovery and Design. Future Science Book Series. Future Science Ltd. pp. 178–188. doi:10.4155/ebo.13.417. ISBN 978-1-909453-01-2.
  23. ^ Deyon-Jung, Laurence; Morice, Christophe; Chéry, Florence; Gay, Julie; Langer, Thierry; Frantz, Marie-Céline; Rozot, Roger; Dalko-Csiba, Maria (2016-03-16). "Fragment pharmacophore-based in silico screening: a powerful approach for efficient lead discovery". Med. Chem. Commun. 7 (3): 506–511. doi:10.1039/c5md00444f. ISSN 2040-2511.
  24. ^ Golestanian, Sahand; Sharifi, Amirhossein; Popowicz, Grzegorz M.; Azizian, Homa; Foroumadi, Alireza; Szwagierczak, Aleksandra; Holak, Tad A.; Amanlou, Massoud (2016-01-15). "Discovery of novel dual inhibitors against Mdm2 and Mdmx proteins by in silico approaches and binding assay". Life Sciences. 145: 240–246. doi:10.1016/j.lfs.2015.12.047. PMID 26746660.
  25. ^ Wei, Yinxiang; Ma, Yuanfang; Zhao, Qing; Ren, Zhiguang; Li, Yan; Hou, Tingjun; Peng, Hui (2012-08-01). "New Use for an Old Drug: Inhibiting ABCG2 with Sorafenib". Molecular Cancer Therapeutics. 11 (8): 1693–1702. doi:10.1158/1535-7163.MCT-12-0215. ISSN 1535-7163. PMID 22593228.
  26. ^ Shirgahi Talari, Faezeh; Bagherzadeh, Kowsar; Golestanian, Sahand; Jarstfer, Michael; Amanlou, Massoud (2015-12-28). "Potent Human Telomerase Inhibitors: Molecular Dynamic Simulations, Multiple Pharmacophore-Based Virtual Screening, and Biochemical Assays". Journal of Chemical Information and Modeling. 55 (12): 2596–2610. doi:10.1021/acs.jcim.5b00336. ISSN 1549-9596. PMID 26529120.
  27. ^ Rakers, Christin; Schumacher, Fabian; Meinl, Walter; Glatt, Hansruedi; Kleuser, Burkhard; Wolber, Gerhard (2016-01-01). "In Silico Prediction of Human Sulfotransferase 1E1 Activity Guided by Pharmacophores from Molecular Dynamics Simulations". Journal of Biological Chemistry. 291 (1): 58–71. doi:10.1074/jbc.M115.685610. ISSN 0021-9258. PMC 4697188. PMID 26542807.
  28. ^ Wieder, Marcus; Perricone, Ugo; Boresch, Stefan; Seidel, Thomas; Langer, Thierry (2016-02-12). "Evaluating the stability of pharmacophore features using molecular dynamics simulations". Biochemical and Biophysical Research Communications. 470 (3): 685–689. doi:10.1016/j.bbrc.2016.01.081. PMID 26785387.
  29. ^ Malle, E.; Furtmüller, P. G.; Sattler, W.; Obinger, C. (2007). "Myeloperoxidase: a target for new drug development?". British Journal of Pharmacology. 152 (6): 838–854. doi:10.1038/sj.bjp.0707358. PMC 2078229. PMID 17592500.
  30. ^ Barreca, M. L.; De Luca, L.; Iraci, N.; Rao, A.; Ferro, S.; Maga, G.; Chimirri, A (2007). "Structure-Based Pharmacophore Identification of New Chemical Scaffolds as Non-Nucleoside Reverse Transcriptase Inhibitors". J. Chem. Inf. Model. 47 (2): 557–562. doi:10.1021/ci600320q. PMID 17274611.
  31. ^ Steindl, T. M; Schuster, D.; Wolber, G.; Laggner, C.; Langer, T. (2007). "High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screening". J. Comput.-Aided Mol. Des. 20 (12): 703–715. doi:10.1007/s10822-006-9066-y. PMID 17009092. S2CID 32857983.
  32. ^ Steindl, T. M; Schuster, Laggner; Chuang, K.; Hoffmann, R.; Langer, T. (2007). "Parallel Screening and Activity Profiling with HIV Protease Inhibitor Pharmacophore Models". J. Chem. Inf. Model. 47 (2): 563–571. doi:10.1021/ci600321m. PMID 17381173.
  33. ^ Schuster, D.; Laggner, C.; Steindl, T. M.; Langer, T. (2006). "Development and validation of an in silico P450 profiler based on pharmacophore models". Curr. Drug Discov. Technol. 3 (1): 1–48. doi:10.2174/157016306776637609. PMID 16712462.
  34. ^ Krovat, E. M.; Fruhwirth, K. H.; Langer, T. (2005). "Pharmacophore Identification, in Silico Screening, and Virtual Library Design for Inhibitors of the Human Factor Xa". J. Chem. Inf. Model. 45 (1): 146–159. doi:10.1021/ci049778k. PMID 15667140.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Inte:Ligand&oldid=1255853601"